Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB.

IF 1.3 Q4 RESPIRATORY SYSTEM Public Health Action Pub Date : 2023-06-21 DOI:10.5588/pha.22.0041
A Iyer, Z Ndlovu, J Sharma, H Mansoor, M Bharati, S Kolan, M Morales, M Das, P Issakidis, G Ferlazzo, N Hirani, A Joshi, P Tipre, N Sutar, K England
{"title":"Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB.","authors":"A Iyer,&nbsp;Z Ndlovu,&nbsp;J Sharma,&nbsp;H Mansoor,&nbsp;M Bharati,&nbsp;S Kolan,&nbsp;M Morales,&nbsp;M Das,&nbsp;P Issakidis,&nbsp;G Ferlazzo,&nbsp;N Hirani,&nbsp;A Joshi,&nbsp;P Tipre,&nbsp;N Sutar,&nbsp;K England","doi":"10.5588/pha.22.0041","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Phenotypic drug susceptibility testing (pDST) for <i>Mycobacterium tuberculosis</i> can take up to 8 weeks, while conventional molecular tests identify a limited set of resistance mutations. Targeted next-generation sequencing (tNGS) offers rapid results for predicting comprehensive drug resistance, and this study sought to explore its operational feasibility within a public health laboratory in Mumbai, India.</p><p><strong>Methods: </strong>Pulmonary samples from consenting patients testing Xpert MTB-positive were tested for drug resistance by conventional methods and using tNGS. Laboratory operational and logistical implementation experiences from study team members are shared below.</p><p><strong>Results: </strong>Of the total number of patients tested, 70% (113/161) had no history of previous TB or treatment; however, 88.2% (<i>n</i> = 142) had rifampicin-resistant/multidrug-resistant TB (RR/MDR-TB). There was a high concordance between resistance predictions of tNGS and pDST for most drugs, with tNGS more accurately identifying resistance overall. tNGS was integrated and adapted into the laboratory workflow; however, batching samples caused significantly longer result turnaround time, fastest at 24 days. Manual DNA extraction caused inefficiencies; thus protocol optimisations were performed. Technical expertise was required for analysis of uncharacterised mutations and interpretation of report templates. tNGS cost per sample was US$230, while for pDST this was US$119.</p><p><strong>Conclusions: </strong>Implementation of tNGS is feasible in reference laboratories. It can rapidly identify drug resistance and should be considered as a potential alternative to pDST.</p>","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290261/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Action","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/pha.22.0041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Phenotypic drug susceptibility testing (pDST) for Mycobacterium tuberculosis can take up to 8 weeks, while conventional molecular tests identify a limited set of resistance mutations. Targeted next-generation sequencing (tNGS) offers rapid results for predicting comprehensive drug resistance, and this study sought to explore its operational feasibility within a public health laboratory in Mumbai, India.

Methods: Pulmonary samples from consenting patients testing Xpert MTB-positive were tested for drug resistance by conventional methods and using tNGS. Laboratory operational and logistical implementation experiences from study team members are shared below.

Results: Of the total number of patients tested, 70% (113/161) had no history of previous TB or treatment; however, 88.2% (n = 142) had rifampicin-resistant/multidrug-resistant TB (RR/MDR-TB). There was a high concordance between resistance predictions of tNGS and pDST for most drugs, with tNGS more accurately identifying resistance overall. tNGS was integrated and adapted into the laboratory workflow; however, batching samples caused significantly longer result turnaround time, fastest at 24 days. Manual DNA extraction caused inefficiencies; thus protocol optimisations were performed. Technical expertise was required for analysis of uncharacterised mutations and interpretation of report templates. tNGS cost per sample was US$230, while for pDST this was US$119.

Conclusions: Implementation of tNGS is feasible in reference laboratories. It can rapidly identify drug resistance and should be considered as a potential alternative to pDST.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于耐药结核病常规诊断的靶向新一代测序的运作。
背景:结核分枝杆菌的表型药敏试验(pDST)可能需要长达8周的时间,而传统的分子试验鉴定出一组有限的耐药突变。靶向下一代测序(tNGS)为预测全面耐药性提供了快速结果,本研究试图在印度孟买的一个公共卫生实验室探索其操作可行性。方法:采用常规方法和tNGS对Xpert mtb阳性患者肺标本进行耐药检测。下面分享了研究小组成员的实验室操作和后勤实施经验。结果:在接受检测的患者总数中,70%(113/161)没有结核病史或治疗史;然而,88.2% (n = 142)患有利福平耐药/耐多药结核病(RR/MDR-TB)。对于大多数药物,tNGS和pDST的耐药预测之间存在高度一致性,tNGS总体上更准确地识别耐药。将tNGS整合并适应到实验室工作流程中;然而,批量样品导致结果周转时间明显延长,最快为24天。人工DNA提取效率低下;因此,执行了协议优化。分析无特征的突变和解释报告模板需要技术专门知识。每个样品的tNGS成本为230美元,而pDST的成本为119美元。结论:在参比实验室实施tNGS是可行的。它可以快速识别耐药性,应被视为pDST的潜在替代品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Public Health Action
Public Health Action RESPIRATORY SYSTEM-
自引率
0.00%
发文量
29
期刊介绍: Launched on 1 May 2011, Public Health Action (PHA) is an official publication of the International Union Against Tuberculosis and Lung Disease (The Union). It is an open access, online journal available world-wide to physicians, health workers, researchers, professors, students and decision-makers, including public health centres, medical, university and pharmaceutical libraries, hospitals, clinics, foundations and institutions. PHA is a peer-reviewed scholarly journal that actively encourages, communicates and reports new knowledge, dialogue and controversy in health systems and services for people in vulnerable and resource-limited communities — all topics that reflect the mission of The Union, Health solutions for the poor.
期刊最新文献
TB burden and diagnostic challenges at Sandaun Provincial Hospital in West Sepik Province of PNG, 2016-2021. TB-related technical enquiries received at the Research Institute of Tuberculosis, Japan, during COVID-19. Continuous quality improvement in a community-wide TB screening and prevention programme in Papua New Guinea. Effects of extrapulmonary TB on patient quality of life and recurrence. Impact of Truenat on TB diagnosis in Nigeria.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1